Pengaruh Ukuran Perusahaan, Intensitas Modal dan Intensitas Persediaan terhadap Agresivitas Pajak
Jurnal Nusa Akuntansi · 22.09.2024 · 1 (3) · 610-627
DOI: 10.62237/jna.v1i3.113 ↗Kurz gefasst
Fachartikel in der Zeitschrift Jurnal Nusa Akuntansi, online erschienen am 22.09.2024. Verfasst von Riky Ardiansyah und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Abstract (Originalsprache)
This research aims to analyze the influence of Company Size, Capital Intensity, Inventory Intensity on Tax Aggressiveness. This type of research is quantitative with secondary data sources. The population in this research is industrial sector companies listed on the Indonesia Stock Exchange (IDX) in 2018-2022. The sample selection method used in this research was purposive sampling so that the final sample obtained was 12 companies. The analysis technique used in this research uses multiple linear regression analysis techniques. The research results show that simultaneously the variables Company Size, Capital Intensity, Inventory Intensity influence Tax Aggressiveness. Then partially it shows that Company Size, Capital Intensity, Inventory Intensity do not have a significant effect on Tax Aggressiveness
Zitieren
APA
Ardiansyah, R., & Fikriyah, S. H. (2024). Pengaruh Ukuran Perusahaan, Intensitas Modal dan Intensitas Persediaan terhadap Agresivitas Pajak. Jurnal Nusa Akuntansi, 1(3), 610-627. https://doi.org/10.62237/jna.v1i3.113
Vancouver
Ardiansyah R, Fikriyah SH. Pengaruh Ukuran Perusahaan, Intensitas Modal dan Intensitas Persediaan terhadap Agresivitas Pajak. Jurnal Nusa Akuntansi. 2024;1(3):610-627. doi:10.62237/jna.v1i3.113
BibTeX
@article{Ardiansyah2024,
author = {Ardiansyah, Riky and Fikriyah, Siti Hailatul},
title = {Pengaruh Ukuran Perusahaan, Intensitas Modal dan Intensitas Persediaan terhadap Agresivitas Pajak},
journal = {Jurnal Nusa Akuntansi},
year = {2024},
volume = {1},
number = {3},
pages = {610--627},
doi = {10.62237/jna.v1i3.113}
}
EUVIMED